|
COPYRIGHT 2004 International Medical News Group
Vesicare
(solifenacin succinate, Yamanouchi Pharmaceutical Co.)
A muscarinic receptor antagonist for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
* Recommended Dosage: 5 mg once a day; if well tolerated, can be increased to 10 mg once a day. No more than 5 mg daily for patients with renal or moderate hepatic impairment, and those taking CYP3A4 inhibitors, such as ketoconazole. Not recommended for patients with severe hepatic...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
